John W. Rogers Jr.
Ariel Appreciation Fund
Ariel Appreciation Fund Portfolio 13F
John W. Rogers Jr. Holdings Activity
- Portfolio value:
- $1.01B≈ (+$48M≈)
- Previous value:
- $963.09M≈
- # of changes:
- 30
- New positions:
- 0
- Reported for:
- 30 Sep 2024 (Q3)
- Latest filing date:
- 18 Nov 2024
Ariel Appreciation Fund has disclosed a total of 30 changes to the portfolio in the (2024 Q3) SEC report(s): increased the number of shares of 13, decreased the number of shares of 15 and completely sold out 2 position(s).
What stocks did John W. Rogers Jr. buy in 2024 Q3?
During 2024 Q3 John W. Rogers Jr. has bought 13 securities out of which top 5 purchases (by % change to portfolio) were (CG) Carlyle Group Inc (added shares +5.97%), (FAF) First American Corp (added shares +4.81%), (NVST) Envista Holdings Corp (added shares +22.68%), (SCHW) Charles Schwab Corp (added shares +15.44%) and (BIO) Bio-Rad Laboratories Inc (added shares +29.05%).
In the 2024 Q3 report(s) the following changes have been made to the top investments: (NTRS) Northern Trust Corp (reduced shares -14.66%), (GS) Goldman Sachs Group Inc (reduced shares -18.64%), (GNRC) Generac Holdings Inc (reduced shares -8.67%) and (SWK) Stanley Black & Decker Inc (reduced shares -6.56%).
30 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Middleby Corp
|
+101.06%
|
+79,281
|
157,729
|
+1.09%
|
$139.13
|
-3.79%($133.86)
|
2.17%
|
2024 Q2
|
≈ 0.50 years
|
|
|
|
Bio-Rad Laboratories Inc
|
+29.05%
|
+15,025
|
66,738
|
+0.5%
|
$334.58
|
-2.85%($325.05)
|
2.21%
|
2024 Q1
|
≈ 0.75 years
|
|
|
|
Envista Holdings Corp
|
+22.68%
|
+229,940
|
1,243,759
|
+0.45%
|
$19.76
|
+38.69%($27.40)
|
2.43%
|
2020 Q1
|
≈ 4.75 years
|
|
|
|
BorgWarner Inc
|
+19.16%
|
+85,954
|
534,514
|
+0.31%
|
$36.29
|
+76.19%($63.94)
|
1.92%
|
2019 Q3
|
≈ 5.25 years
|
|
|
|
Gentex Corp
|
+16.76%
|
+97,509
|
679,458
|
+0.29%
|
$29.69
|
-21.08%($23.43)
|
1.99%
|
2021 Q3
|
≈ 3.25 years
|
|
|
|
Charles Schwab Corp
|
+15.44%
|
+49,607
|
370,880
|
+0.32%
|
$64.81
|
+62.32%($105.20)
|
2.38%
|
2020 Q1
|
≈ 4.75 years
|
|
|
|
Molson Coors Brewing Co, CL-B
|
+14.86%
|
+38,863
|
300,304
|
+0.22%
|
$57.52
|
-28.06%($41.38)
|
1.71%
|
2019 Q3
|
≈ 5.25 years
|
|
|
|
NOV Inc
|
+8.37%
|
+103,928
|
1,345,112
|
+0.16%
|
$15.97
|
+20.63%($19.26)
|
2.12%
|
2019 Q3
|
≈ 5.25 years
|
|
|
|
Carlyle Group Inc
|
+5.97%
|
+36,519
|
648,153
|
+0.16%
|
$43.06
|
+6.08%($45.68)
|
2.76%
|
2023 Q2
|
≈ 1.50 years
|
|
|
|
First American Corp
|
+4.81%
|
+18,289
|
398,697
|
+0.12%
|
$66.01
|
+13.80%($75.12)
|
2.60%
|
2019 Q3
|
≈ 5.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.